|
|
Volumn 152, Issue , 1998, Pages 328-340
|
|
Tailored chemotherapy to equal toxicity: is it possible?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLOOD EXAMINATION;
BODY SURFACE;
BREAST TUMOR;
DOSE RESPONSE;
DRUG MONITORING;
FEMALE;
HUMAN;
METABOLISM;
PHASE 1 CLINICAL TRIAL;
REVIEW;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
BODY SURFACE AREA;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE I;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG MONITORING;
FEMALE;
HEMATOLOGIC TESTS;
HUMANS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 0032232998
PISSN: 00800015
EISSN: None
Source Type: Journal
DOI: 10.1007/978-3-642-45769-2_32 Document Type: Review |
|
Times cited : (15)
|
|
References (28)
|
